The randomized trial aims to determine if concentrated bone marrow aspirate can prevent chronic inflammation and osteoarthritis in ACL revision patients, according to a May 20 news release. Past research suggests that concentrated bone marrow aspirate could improve surgical outcomes but it hasn’t been studied in rigorous clinical trials yet.
The concentrated bone marrow aspirate in the study will come from the patient’s own pelvic bones.
The Center for Regenerative Medicine at Hospital for Special Surgery is leading the trial, and Emory University in Atlanta will serve as a sub-site for research.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
